Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 25 - Drugs for disorders of the nervous system
Patents for A61P 25 - Drugs for disorders of the nervous system (183,225)
10/1999
10/21/1999CA2369172A1 Ste20-related protein kinases
10/21/1999CA2328878A1 Thienylazolylalcoxyethanamines, their preparation and their application as medicaments
10/21/1999CA2328360A1 Improvements in or relating to protease inhibitors
10/21/1999CA2328211A1 Substituted pyrrolidine hydroxamate metalloprotease inhibitors
10/21/1999CA2327782A1 Azabicyclic 5ht1 receptor ligands
10/21/1999CA2327477A1 4-amino-(ethylamino)-oxindole dopamine autoreceptor agonists
10/21/1999CA2327450A1 Paroxetine maleate
10/21/1999CA2327431A1 Pharmaceutical composition
10/21/1999CA2325629A1 Crystalline forms of 1s-[1alpha (2s*,3r*), 9alpha]-6, 10-dioxo-n- (2-ethoxy-5 -oxo-tetrahydro-3 -furanyl) -9-[[(1-isoquinolyl) carbonyl]-amino] octahydro-6h -piridazino[1, 2-a][1,2] diazepin- 1-carboxamide
10/21/1999CA2325603A1 Pns cell lines and methods of use therefor
10/21/1999CA2325559A1 Non-endogenous, constitutively activated human serotonin receptors and small molecule modulators thereof
10/21/1999CA2325332A1 Therapeutic agent for ngf
10/21/1999CA2321157A1 New treatments for nervous disorders
10/21/1999CA2320722A1 New treatments for nervous disorders
10/20/1999EP0950408A1 Oily patches for external use containing diclofenac sodium
10/20/1999EP0950406A2 Remedy for CAG repeat expansion diseases
10/20/1999EP0950058A1 Spiro-substituted azacyclic-substituted piperazino derivatives as neurokinin antagonists
10/20/1999EP0950057A1 3-pyridyl enantiomers and their use as analgesics
10/20/1999EP0950056A2 N-(pyridinylamino)isoindolines and related compounds
10/20/1999EP0950053A1 Use of benzoylalkyl-1,2,3,6-tetrahydropyridins
10/20/1999EP0950049A1 Diphenyl alkyl-tetrahydropyridines, process for their preparation, and pharmaceutical compositions containing them
10/20/1999EP0950048A1 1-phenylalkyl-1,2,3,6-tetrahydropyridines for treating alzheimer's disease
10/20/1999EP0950047A1 Indolin-2-one derivatives, method for preparing them and pharmaceutical compositions containing them
10/20/1999EP0949925A2 Flat medicament preparation for the application and release of buprenorphine or a pharmacologically comparable substance in the buccal cavity, and method of producing the same
10/20/1999EP0949922A1 Pharmaceutical compositions and methods of treating compulsive disorders using naaladase inhibitors
10/20/1999EP0949920A1 Highly selective butyrylcholinesterase inhibitors for the treatment and diagnosis of alzheimer's disease and dementias
10/20/1999EP0949917A1 Substances and their uses
10/20/1999EP0767659B1 Transdermal administration of oxybutynin
10/20/1999CN1232469A RET ligand (RetL) for stimulating neural and renal growth
10/20/1999CN1232462A Muscarinic antagonists
10/20/1999CN1232453A Ether muscarinic antagonists
10/20/1999CN1232452A NMDA (N-methyl-D-aspartate) antagonists
10/20/1999CN1232448A Vitamin D analogues
10/20/1999CN1232400A Anti-stress drugs and functional foods having anti-stress effects
10/20/1999CN1232394A Solid oral dosage forms of valsartan
10/20/1999CN1232393A Anticonvulsant drivs. useful in treating neuropathic pain
10/20/1999CN1232391A Pharmaceutical microspheres of valproic acid for oral administration
10/20/1999CN1232387A Galenic formula with extended release of milnacipran
10/20/1999CN1232087A Polynucleotide molecules encoding neospora proteins
10/20/1999CN1232025A Pyrrolidine and piperidine derivatives
10/20/1999CN1045778C Novel chemical compounds having P.DE-IV inhibition activity
10/20/1999CN1045774C Substd. arylthioalkylthiopyridines, their preparing method and pharmaceutical use
10/20/1999CN1045768C Angiotension II antagonists compounds, preparing method and use thereof
10/20/1999CN1045767C Pyrazole derivs, processes for preparation thereof and pharmaceutical composition comprising same
10/19/1999US5969184 Amide compounds
10/19/1999US5969146 Monoamine oxidase inhibitors
10/19/1999US5969134 Cardiovascular disorders, vasoconstriction, hypotensive agents and release of endothelins
10/19/1999US5969100 Peptide, peptide analog and amino acid analog protease inhibitors
10/19/1999US5968971 Endothelin receptor antagonists
10/19/1999US5968969 Stable, long acting salts of carboxamides for the treatment of joint disease
10/19/1999US5968957 Administering to effect neuronal activity
10/19/1999US5968955 Disubstituted piperidine derivatives as neuroprotective agents
10/19/1999US5968954 Exhibit selective binding affinity for 5-hydroxytryptamine receptors
10/19/1999US5968953 For side effect reduction
10/19/1999US5968951 Benzenesulfonamide derivatives as bradykinin antagonists
10/19/1999US5968949 Substituted hydroisoquinoline derivatives and their use as pharmaceuticals
10/19/1999US5968948 Annelated dihydropyridines and the use thereof for preparing pharmaceutical preparations
10/19/1999US5968946 Heterocyclic derivatives useful in treating central nervous system disorders
10/19/1999US5968944 Substituted pyrazoles as corticotropin-releasing factor (CRF) antagonists
10/19/1999US5968934 Treatment of pain, inflammation, migraines, emesis and postherapeutic neuralgia
10/19/1999US5968926 Schizophrenia treatment with 1,2,5-oxadiazole or 1,2,5-thiadiazole
10/19/1999US5968923 (Azetidin-1-ylalkyl) lactams as tachykinin antagonists
10/19/1999US5968921 Compositions and methods for promoting nerve regeneration
10/19/1999US5968826 Antisense inhibition of integrin α4 expression
10/19/1999US5968819 DNA encoding a hypothalamic atypical neuropeptide Y/peptide YY receptor (Y5)
10/19/1999US5968747 Polynucleotide encoding polypeptide; therapy for prevention and treatment of cancer, autoimmune diseases, developmental defects, nervous system disorders
10/19/1999US5968547 Method of providing sustained analgesia with buprenorphine
10/19/1999US5968520 Plant extracts from alder and mountain ash; hangover remedy
10/16/1999CA2269049A1 N-acyl and n-aroyl aralkyl amides
10/14/1999WO1999051994A1 Pharmacological mri (phmri)
10/14/1999WO1999051732A1 Secreted proteins and polynucleotides encoding them
10/14/1999WO1999051626A2 Template associated npy y2-receptor agonists
10/14/1999WO1999051608A1 THIAZOLO[4,5-d]PYRIMIDINES AND PYRIDINES AS CORTICOTROPIN RELEASING FACTOR (CRF) ANTAGONISTS
10/14/1999WO1999051602A1 Azatricyclo[3.3.1.1] decane derivatives and pharmaceutical compositions containing them
10/14/1999WO1999051601A1 Azatricyclic compounds
10/14/1999WO1999051600A1 AMINOALKYL SUBSTITUTED 9H-PYRIDINO[2,3-b]INDOLE AND 9H-PYRIMIDINO[4,5-b]INDOLE DERIVATIVES
10/14/1999WO1999051599A1 Aminoalkyl substituted pyrrolo[2,3-b]pyridine and pyrrolo[2,3-d]pyrimidine derivatives: modulators of crf1 receptors
10/14/1999WO1999051597A1 Aminoalkyl substituted 5,6,7,8-tetrahydro-9h pyrimidino[2,3-b]indole and 5,6,7,8-tetrahydro-9h-pyrimidino[4,5-b]indole derivatives: crf1 specific ligands
10/14/1999WO1999051596A1 Antagonists of gonadotropin releasing hormone
10/14/1999WO1999051595A1 Antagonists of gonadotropin releasing hormone
10/14/1999WO1999051594A1 IMIDAZO[1,2-a]PYRIDINES AS PERIPHERAL BENZODIAZEPINE RECEPTOR BINDING AGENTS
10/14/1999WO1999051592A1 Indol-3-yl-cyclohexyl amine derivatives for the treatment of depression (5-ht1 receptor antagonists)
10/14/1999WO1999051591A2 N-aryloxyethyl-indoly-alkylamines for the treatment of depression
10/14/1999WO1999051576A1 N-aryloxyethylamine derivatives for the treatment of depression
10/14/1999WO1999051575A1 N-aryloxyethyl-indoly-alkylamines for the treatment of depression (5-ht1a receptor active agents)
10/14/1999WO1999051565A1 Novel local anesthetic compounds and uses
10/14/1999WO1999051254A1 Short peptides for treatment of neurological degenerative diseases
10/14/1999WO1999051240A1 Acylbenzoxazines for enhancing synaptic response(s)
10/14/1999WO1999051233A1 Antagonists of gonadotropin releasing hormone
10/14/1999WO1999051229A1 Treatment of panic attacks
10/14/1999WO1999051217A1 Inhibition of binding of hox and homeodomain-containing proteins and uses thereof
10/14/1999WO1999051216A2 3-pyridyloxyalkylamine or aryloxyalkylamine derivatives as cholinergic agonists
10/14/1999WO1999051203A1 Maximizing effectiveness of substances used to improve health and well being
10/14/1999WO1999051186A2 Methods and compositions for the diagnosis and treatment of neuropsychiatric disorders
10/14/1999WO1999051097A1 Compositions containing a combination of a creatine compound and a second agent
10/14/1999WO1999045011A8 Glycine transport inhibitors
10/14/1999WO1999044623A8 Compositions comprising valerian extracts, isovaleric acid or derivatives thereof with a nsaid
10/14/1999WO1999042089A3 Use of thiadiazolo[4,3-a]pyridine derivatives
10/14/1999WO1999028343A9 Hydrophobically-modified protein compositions and methods
10/14/1999DE19814087A1 Feuchtigkeitsaktivierbares therapeutisches System Moisture-activatable therapeutic system
1 ... 1536 1537 1538 1539 1540 1541 1542 1543 1544 1545 1546 1547 1548 1549 1550 1551 1552 1553 1554 1555 1556 ... 1833